Palobiofarma

Developer of pharmaceutical drugs based on modulation of adenosine receptors

placeMataro, Catalonia, Spain calendar_todayFounded 2006 groups19 employees language palobiofarma.com

Social engagement

Social engagement: 1.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Sodena, Inveready, Fitalent.

Investor typeCountShare
Venture capital457%
Accelerator & incubator114%
Other / undisclosed229%
Coming soon